A Belgian multicentre in-vitro study of ofloxacin
In a large multicentre study, the susceptibility of 2171 bacterial isolates to ofloxacin and other antibiotics has been examined by the Kirby-Bauer method. Susceptibility to ofloxacin (breakpoint ⩽2 mg/1) was observed in 99·2% of 1104 strains Enterobacteriaceae,88·9% of 217 Pseudomonas aeruginosa, 93·6% of 31 other Pseudomonas spp.,96·3% of 27 Acinetobacter calcoaceticus,99·2% of 118 Haemophilus influenzae,97·4% of 423 staphylococci,79·4% of 107 Streptococcus faecalis and 98·7% of 142 other streptococci. There was no relationship between resistance to ofloxacin and resistance to β-lactam antib... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | TEXT |
| Erscheinungsdatum: | 1988 |
| Verlag/Hrsg.: |
Oxford University Press
|
| Schlagwörter: | Articles |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-27312094 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://jac.oxfordjournals.org/cgi/content/short/22/Supplement_C/35 |
In a large multicentre study, the susceptibility of 2171 bacterial isolates to ofloxacin and other antibiotics has been examined by the Kirby-Bauer method. Susceptibility to ofloxacin (breakpoint ⩽2 mg/1) was observed in 99·2% of 1104 strains Enterobacteriaceae,88·9% of 217 Pseudomonas aeruginosa, 93·6% of 31 other Pseudomonas spp.,96·3% of 27 Acinetobacter calcoaceticus,99·2% of 118 Haemophilus influenzae,97·4% of 423 staphylococci,79·4% of 107 Streptococcus faecalis and 98·7% of 142 other streptococci. There was no relationship between resistance to ofloxacin and resistance to β-lactam antibiotics, aminoglycosides or other antibiotics tested within the same bacterial species.